MAPT and epilepsy: Since our analysis only included individuals who were diagnosed with epilepsy after the Alzheimer’s disease diagnosis, the selective difference detected in our material for tau and Aβ42 could indicate that epilepsy develops in patients with a more severe Alzheimer’s disease trajectory.